nanowires
NanoDiagnostics Closes $18M Series C Round
The funding will be used to continue work on a blood-based test for the detection of concussions at the point of care, point of injury, or at a remote testing site.
BioDirection Inks Agreement With EU-Backed Alliance for Concussion Test Evaluation, Development
BioDirection is collaborating with CENTER-TBI, an EU initiative that aims to advance the care of patients with traumatic brain injury.
The firm is part of a research consortium that is led by Mount Sinai and includes Fluidigm to develop a device to detect epigenetic signatures of WMD exposure.
Given the high yield of miRNA markers they were able to isolate, the researchers believe the approach could be commercialized for routine cancer testing.
BioDirection Closes $2M Interim Financing for Concussion Test Development
The funding will go toward clinical development of Tbit, which BioDirection said can offer an objective diagnosis of traumatic brain injuries in 90 seconds.